DM Full Guideline (2010) - VA/DoD Clinical Practice Guidelines Home

Version 4.0
VA/DoD Clinical Practice Guideline
for the Management of Diabetes Mellitus
Golightly LK, Jones MA, Hamamura DH et al. Management of diabetes mellitus in hospitalized patients:
efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy 2006; 26(10): 1421-32.
Goudswaard AN, Furlong NJ, Rutten GE et al. Insulin monotherapy versus combinations of insulin with oral
hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane Database Syst Rev 2004(4):
CD003418.
Gray CS, Hildreth AJ, Sandercock PA et al. Glucose-potassium-insulin infusions in the management of post-stroke
hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol 2007; 6(5): 397-406.
Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic
control. Endocr Pract 2004; 10(Suppl 2): 46-52.
Griesdale DE, de Souza RJ, van Dam RM et al. Intensive insulin therapy and mortality among critically ill
patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180(8): 821-7; discussion 799-
800.
Hansen HP, Gaede PH, Jensen BR et al. Lack of impact of low-dose acetylsalicylic acid on kidney function in type
1 diabetic patients with microalbuminuria. Diabetes Care 2000; 23(12): 1742-5.
Harding SP, Broadbent DM, Neoh C, White MC, Vora J. Sensitivity and specificity of photography and direct
ophthalmoscopy in screening for sight threatening eye disease: the Liverpool Diabetic Eye Study. BMJ.
1995 Oct 28;311(7013):1131-5.
Harris MI. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
Diabetes Care 2001; 24(6): 979-82.
Heine RJ, Van Gaal LF, Johns D et al. Exenatide versus insulin glargine in patients with suboptimally controlled
type 2 diabetes: a randomized trial. Ann Intern Med 2005; 143(8): 559-69.
Herman WH, Dungan KM, Wolffenbuttel BH et al. Racial and ethnic differences in mean plasma glucose,
hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol
Metab 2009; 94(5): 1689-94.
Herman WH, Ilag LL, Johnson SL et al. A clinical trial of continuous subcutaneous insulin infusion versus
multiple daily injections in older adults with type 2 diabetes. Diabetes Care 2005; 28(7): 1568-73.
Herman WH, Ma Y, Uwaifo G et al. Differences in A1C by race and ethnicity among patients with impaired
glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007; 30(10): 2453-7.
Hermansen K, Davies M, Derezinski T et al. A 26-week, randomized, parallel, treat-to-target trial comparing
insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people
with type 2 diabetes. Diabetes Care 2006; 29(6): 1269-74.
Hermansen K, Kipnes M, Luo E et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in
patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and
metformin. Diabetes Obes Metab 2007; 9(5): 733-45.
Hirsch IB, Bode BW, Garg S et al. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus
multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with
CSII. Diabetes Care 2005; 28(3): 533-8.
Holewski JJ, Stess RM, Graf PM et al. Aesthesiometry: quantification of cutaneous pressure sensation in diabetic
peripheral neuropathy. J Rehabil Res Dev 1988; 25(2): 1-10.
Hollander P, Li J, Allen E et al. Saxagliptin added to a thiazolidinedione improves glycemic control in patients
with type 2 diabetes and inadequate control on thiazolidinedione alone. J Clin Endocrinol Metab 2009;
94(12): 4810-9.
Holman RR, Paul SK, Bethel MA et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J
Med 2008; 359(15): 1577-89.
Hoogma RP, Hammond PJ, Gomis R et al. Comparison of the effects of continuous subcutaneous insulin infusion
(CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life:
results of the 5-nations trial. Diabet Med 2006; 23(2): 141-7.
Horvath K, Jeitler K, Berghold A et al. Long-acting insulin analogues versus NPH insulin (human isophane
insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 20072): CD005613.
Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N Engl J Med 2006; 355(18):
1903-11.
Appendices Page 137